Last reviewed · How we verify

Nebulized Budesonide

AAADRS Clinical Research Center · FDA-approved active Small molecule ✓ Verified May 2026 Quality 5/100

Nebulized Budesonide is a Small molecule drug developed by AAADRS Clinical Research Center. It is currently FDA-approved. Also known as: Pulmicort Respules 0.5mg/2ml nebulized, Pulmicort.

Nebulized Budesonide is a small molecule that acts as a glucocorticoid receptor agonist, used to treat various respiratory conditions such as asthma and acute asthma. It is administered via nebulization, typically in a 0.5 mg/ml solution, to exert its therapeutic effects.

At a glance

Generic nameNebulized Budesonide
Also known asPulmicort Respules 0.5mg/2ml nebulized, Pulmicort
SponsorAAADRS Clinical Research Center
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Nebulized Budesonide

What is Nebulized Budesonide?

Nebulized Budesonide is a Small molecule drug developed by AAADRS Clinical Research Center.

Who makes Nebulized Budesonide?

Nebulized Budesonide is developed and marketed by AAADRS Clinical Research Center (see full AAADRS Clinical Research Center pipeline at /company/aaadrs-clinical-research-center).

Is Nebulized Budesonide also known as anything else?

Nebulized Budesonide is also known as Pulmicort Respules 0.5mg/2ml nebulized, Pulmicort.

What development phase is Nebulized Budesonide in?

Nebulized Budesonide is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing